Company intelligence
Endpoints News
The biopharma world is here
Online Audio and Video Media
Lawrence, US
62 employees
Founded 2014
6 public signals
About Endpoints News
Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the intersection of science, money and power in the world's most innovative industry, and are a part of the Financial Times' FT Specialist group.
Verified activity
Signals from Endpoints News
6 published signals
Research & Knowledge
Endpoints News published a new story analyzing the trend of AI chatbots connecting medical records and regulatory frameworks, citing over 160 companies.
Reported by Shelby Livingston
Capital & Finance
Endpoints News reported that BrainChild Bio, a Seattle Children's spinout creating CAR-T therapies for brain tumors in both children and adults, has collected $116 million to get into pivotal testing.
Reported by Kyle LaHucik
Capital & Finance
Endpoints News reported that a biotech company led by former I-Mab CEO Joan Shen secured more than $80 million in Series B funds from Lilly Asia Ventures and other China venture groups to test NeuShen Therapeutics for schizophrenia, agitation associated with Alzheimer’s disease, treatment-related depression, focal onset seizures, and major depression.
Reported by Kyle LaHucik
Presence & Recognition
Endpoints News is hosting an annual Boston gathering to recognize 11 of the most promising startups in biopharma.
Reported by Andrew Dunn
Presence & Recognition
Endpoints News will unveil the list of the 11 most exciting biotech startups of 2026 on Sept. 24 in Boston.
Reported by Drew Armstrong
Capital & Finance
Endpoints News reports that Lilly's dealmaking sprint has turned into a marathon with at least one acquisition per month so far in 2026, leading to payouts for more than 50 investors.
Reported by Kyle LaHucik